Iron Sucrose 500mg Injection Treatment Regimen for Iron Deficiency Anemia
Intravenous iron sucrose 500mg should be administered as two separate 250mg infusions, each diluted in a maximum of 250mL of 0.9% NaCl, given over 15-30 minutes, with the doses separated by at least one week. 1, 2, 3
Indications for IV Iron Sucrose
IV iron sucrose is indicated when:
- Patient does not tolerate oral iron
- Ferritin levels do not improve with oral iron trial
- Patient has a condition where oral iron absorption is compromised 1
- Hemoglobin is below 10 g/dL requiring rapid correction 2
- Patient has inflammatory bowel disease with active inflammation 1
- Patient has undergone bariatric procedures 1
- Patient has ongoing bleeding who doesn't respond to oral iron therapy 1
Administration Protocol
Dosing:
- Standard single dose: 200-300mg per infusion 2, 3
- For 500mg total dose: Split into two 250mg infusions
- Each mL of iron sucrose contains 20mg of elemental iron 3
Administration Method:
- Dilution: Dilute 250mg in maximum 100-250mL of 0.9% NaCl 3
- Infusion Rate: Administer over 15-30 minutes 2, 3
- Frequency: Space doses at least one week apart
- No test dose required: Unlike older iron formulations, no test dose is needed 1, 3
Monitoring and Response Assessment
- Check hemoglobin 2-4 weeks after treatment 2
- Target increase: At least 2 g/dL within 4 weeks 2
- Check iron parameters (ferritin, transferrin saturation) 8-10 weeks after infusion 2
- Target parameters:
- Hemoglobin: 10-12 g/dL
- Ferritin: >100 ng/mL
- Transferrin saturation: >20% 2
Safety Considerations
- True anaphylaxis is very rare (less than 1:200,000 administrations) 1, 2
- Most reactions are complement activation-related pseudo-allergy (infusion reactions) 1
- Have resuscitation facilities available during administration 2
- Monitor vital signs during and after infusion
- No special precautions needed for patients with previous iron dextran sensitivity 4
Clinical Efficacy
Iron sucrose has demonstrated significant efficacy in:
- Rapidly increasing hemoglobin levels (average increase of 3.29 g/dL for women and 4.58 g/dL for men) 5
- Improving ferritin and transferrin saturation levels 6, 4
- Achieving response rates (hemoglobin increase ≥2 g/dL) in 84-94% of patients 5
Common Pitfalls and Caveats
- Avoid underdilution: Always dilute to recommended concentration to minimize adverse effects
- Don't exceed recommended infusion rate: Faster administration increases risk of reactions
- Don't miss follow-up monitoring: Failure to check response may lead to under-treatment
- Consider underlying conditions: Treat active inflammation in IBD to enhance iron absorption 1
- Avoid substituting with iron sucrose similars: These may have different efficacy and safety profiles 6
Iron sucrose is a well-established, effective, and generally well-tolerated treatment for iron deficiency anemia with over 70 years of clinical experience 6.